论文部分内容阅读
癌胚抗原(CEA)测定是癌的免疫学检查方法之一,近年来受到重视。为了探讨癌与胚性蛋白的关系以及头颈部癌病人血清CEA的临床意义,作者们对73例头颈部癌(包括鳞状上皮癌61例,腺癌11例,未分化癌1例)进行了研究。对照组24例为非癌疾病(包括非上皮性的恶性瘤,良性瘤和炎症等),应用Hansen介绍的氧锆基凝胶法测定病人血清的CEA值。结果:(1)全部癌肿病人的CEA值(平均5.08ng/ml)比非癌肿瘤(平均2.69ng/ml)高。(2)腺癌病人的CEA值(平均6.35ng/ml)比
Carcinoembryonic antigen (CEA) measurement is one of immunological tests for cancer, and has received increasing attention in recent years. To investigate the relationship between cancer and embryonic proteins and the clinical significance of serum CEA in head and neck cancer patients, the authors examined 73 head and neck cancers (including squamous cell carcinoma in 61 cases, adenocarcinoma in 11 cases, and undifferentiated carcinoma in 1 case). Were studied. In the control group, 24 cases were non-cancerous diseases (including non-epithelial malignancies, benign tumors, and inflammation). The zirconyl-based gel method described by Hansen was used to measure the CEA value of the patient’s serum. Results: (1) CEA values (mean 5.08 ng/ml) were higher in all cancer patients than non-cancer tumors (mean 2.69 ng/ml). (2) CEA values (average 6.35 ng/ml) of adenocarcinoma patients